Drugs / wild strain inactivated poliovirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03822754 Comparator | Jun → Sep 2018 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | wild strain inactivated poliovirus vaccine | “The control wild strain inactivated poliovirus vaccine (wIPV) was manufactured by SANOFI PASTEUR S.A.” NCT03822754 ↗ |
| Known as | wIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822754 ↗ |
| Modality | Vaccine | “control wild strain inactivated poliovirus vaccine (wIPV)” NCT03822754 ↗ |
| Route | Intramuscular | “Single intramuscular injection of the control wIPV (0.5 ml)” NCT03822754 ↗ |